Report Brief

The report covers forecast and analysis for the central venous catheters market on a global and regional level

The report includes the positive and the negative factors that are affecting the growth of the central venous catheters market

The market opportunities are discussed in detail

The overall revenue generated by the prominent industry players has been analyzed in the report

The market numbers have been calculated using the top-down and the bottom-up approaches

The central venous catheters market has been analyzed using the Porters Five Forces Analysis

The market is segmented on the basis of design, product type, property, material, applications, and the end-user which, in turn, is categorized on the regional level as well

All the segments have been evaluated based on the present and the future trends

The report deals with the in-depth quantitative and qualitative analyses of the central venous catheters market

The report includes the detailed company profiles of the prominent market players

Market Summary


Overview


The central venous catheters are alternatively known as central venous access devices or central lines catheter. It is a thin, long, hollow plastic tube which is inserted through an internal jugular vein, femoral vein, and subclavian vein. With the help of the catheter, nutrients and medications are given and it is also used for collecting the blood samples.


Value


The global central venous catheters market was valued at around USD 740.0 million in 2016 and is expected to reach around USD 1,140.0 million by the end of 2025, growing at a CAGR of 4.9%between 2017 and 2025.


Drivers and Restraints


The central venous catheters are used for measuring the central venous pressure, monitoring the hemodynamic variables, chemotherapy, and in hemodialysis. Patients suffering from cancer, gastrointestinal diseases, and other chronic diseases require parenteral nutrition which is provided through catheters thus increasing its sales. The increasing number of cancer and cardiovascular patients, aging population, and people suffering from various chronic disorders are the factors that are driving the central venous catheters market.


There are certain complications associated with the use of central venous catheters which may lead to serious morbidity and mortality thus limiting the growth of the market.


Segmentation


The popularity of multi-lumen catheters is increasing owing to its usage in the administration of more than one medication into the patient as there may be cases where two drugs cannot be mixed together prior to administration. This is expected to fuel the growth of multi-lumen catheters.


The non-tunneled catheters are expected to dominate the global central venous catheters market. As non-tunneled catheters are used for temporary access for the infusion of the medication and other types of fluids its popularity is growing in the global market.


The non-antimicrobial coated central venous catheters segment contributed a major market share of over 64% in 2017. But, as there are high chances of getting bloodstream infections among the recipients the manufacturers are focusing on the production of the antimicrobial coated catheters and are investing majorly in the RD activities to combat this situation. Thus antimicrobial coated catheters are expected to account for a high CAGR in the coming years.


Polyurethane is a new material that has beneficial characteristics such higher stiffness and strength making it preferred material central venous catheters as compared to silicone. Thus polyurethane is occupying larger market share in the central venous catheters market.


The central venous catheters are used increasingly in the hospitals and the ambulatory surgical centers. The hospital segment accounted a market share of over 37% in 2017 thus dominating the global market.A majority of the hospitals provide the facility of performing dialysis procedures for urological and renal disorders thus the influx of the patients has increased considerably in the hospitals.


North America contributed a major share of total revenue generated by central venous catheters market in 2017.The growing awareness in the American population about the antimicrobial technology and the increasing adoption of the antimicrobial central venous catheter is positively impacting the growth of the market.The rapid development of the medical facilities and the well-developed healthcare infrastructure are the other factors driving the growth of the market in this region.


Graphical Representation of Market Growth



Industry Players


The global central venous catheters market report profiles some of the leading players in the market and analyzes their key strategies. The major players in the market are AngioDynamics, B. Braun Melsungen AG, Becton, Dickinson and Company, Citius Pharmaceuticals, Cook Medical, Edwards Lifesciences Corporation, Guangdong Baihe Medical Technology Co., Ltd., Intra Special Catheters GmbH, Kimal, Lepu Medical Technology (Beijing) Co., Ltd., SCW Medicath Ltd., Smiths Medical, Teleflex Incorporated, TuoRen Medical, Vogt Medical, Vygon (UK) Ltd., and ZOLL Medical Corporation.


The prominent market players maintain the competitive edge in the global market by making investments in the mergers and acquisitions and by increasing their product portfolio. For instance, in June 2016, Kimal had launched their new product Altius RT Acute Haemodialysis Catheter which was designed to improve the patients safety.